Posts
IBRX – FDA RMAT Designation Could Be a Huge Catalyst
ImmunityBio (IBRX) just received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for its cancer immunotherapy, ANKTIVA, which targets bladder cancer. This designation is a strong signal that the treatment has significant potential and allows for an expedited regulatory pathway, potentially leading to faster approval and commercialization. If ANKTIVA …
Bloomberg - Singapore Arrests Three in Case Linked to Nvidia Server Fraud
IBRX – FDA RMAT Designation Could Be a Big Catalyst
ImmunityBio (IBRX) just received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for its cancer immunotherapy, ANKTIVA, which targets bladder cancer. This designation is a strong signal that the treatment has significant potential and allows for an expedited regulatory pathway, potentially leading to faster approval and commercialization. If ANKTIVA …
$SANA - the comeback is happening, 8 week interim analysis on Monday
**TL,DR:** Monday SANA Biotechnology will present 8 week interim analysis from their clinical trial curing diabetes, at 4 weeks it was perfect and spiked the stock to 7$, similar will occur Monday/Tuesday and at the 12 weeks analysis results at their earnings call March 23rd. Don't miss it! Listen here …
Carlos Slim orders to cancel his collaboration with Elon Musk's Starlink
Puts lmao
Earnings YOLO! Wish me luck
NVDA's slide today marks the second largest one day loss for a single ticker in history (-$368B)
The top 10 biggest single day losses (so far) are now as follows: 1) NVDA -$589B 01/27/25 2) NVDA -$368B 02/27/25 3) NVDA -$279B 09/04/24 4) META -$251B 02/03/22 5) NVDA -$228B 01/07/25 6) NVDA -$212B 04/19/24 7) NVDA -$208B 06/24/24 8) AMZN -$206B 04/29/22 9) NVDA -$206B 07/17/24 10) …
Nvidia bounced from the $3 trillion market cap club after falling more than 8%
If we go down then we go down together.
We’ve got Tariff Tuesday and a bloodbath jobs report on Friday. Let’s go.
It was rigged from the start. Why SPY ETF is down
https://www.ft.com/content/7ec39633-fa6d-463f-871c-4a05fd86d306